ArticleInfectious diseases and therapy2025

Long-Term Real-World Use of Cabotegravir/Rilpivirine: Adherence and Virological Efficacy over a 44-Month Observation Period.

Catharina Dannenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.